SAGE mRNA expression in advanced-stage lung cancers

European Journal of Surgical Oncology

Volumn 29, Issue 10, 2003, Pages 900-903

  Sasaki, Hidefumi ^a,b   Moriyama, S ^a   Mizuno, K ^a   Yukiue, H ^a   Yano, M ^a   Fukai, I ^a   Yamakawa, Y ^a   Fujii, Y ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

Author keywords

HAGE; LightCycler; Lung cancer; SAGE; Tumour invasion

Indexed keywords

GENE PRODUCT; MESSENGER RNA; PROTEIN HAGE; PROTEIN SAGE; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGE; AGED; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENE ISOLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEX DIFFERENCE; T LYMPHOCYTE;

EID: 0345602091     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2003.06.001     Document Type: Article

References (31)

1. Ministry of Health and Welfare, Statistics and Information Department, Vital Statistics, 1994, Vol. 3.; 1996. Tokyo, p. 96-108.
2. Ginsberg RJ, Kris MK, Armstrong JG. Cancer of the lung. Principles and Practice of Oncology, 4th edn. Philadelphia: Lippincott, 1993: 673-82.
3. On behalf of the Japanese Association for Thoracic Surgery Thoracic and cardiovascular surgery in Japan during 1998, Yasuda K, Ayabe H, Ide H et al. Annual report by the Japanese association for thoracic surgery. Jpn J Thorac Vasc Surg 1998; 48: 401-15.
4. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-7.
5. In: Kazikoe T (ed.) Cancer Statistics in Japan 1997. Tokyo: Foundation for Promotion of Cancer Research, 1997.
6. Strauss GM, et al. Bronchogenic carcinoma. In: Baum GL, Crapo JD, Celli BR, et al. (eds) Textbook of Pulmonary Disease, 6th edn. Philadelphia, PA: Lippincott-Raven, 1998: 1329-81.
7. Hart IR, Saini A. Biology of tumor metastasis. Lancet 1992; 339: 1453-7.
8. Van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on human melanoma. Science 1991; 25: 1643-7.
9. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, Van der Brugge P, Lethe B, Lurquin C, Brasseur R, Chomez P, De Backer O, Cavenee W, Boon T. Structure, chromosomal localization and expression of 12 genes of the MAGE family. Immunogenetics 1994; 46: 360-9.
10. Martelange V, De Smet C, De Plaen E, Lurquin C, Boon T. Identification on human sarcoma of two new genes with tumor-specific expression. Cancer Res 2000; 60: 3848-55.
11. Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S, Boon T. A new family of gene coding for an antigen recognized by autologous cytolytic T lymphocyte on a human melanoma. J Exp Med 1995; 182: 689-98.
12. Gaugler B, Van de Eynde B, Van der Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethe B, Brasseur F. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T-lymphocytes. J Exp Med 1994; 179: 921-30.
13. Boel P, Wildmann C, Sensi ML, Brasseur R, Renauld JC, Coulie P, Boon T, Van der Bruggen P. BAGE: a new gene encoding an antigen recognize on human melanomas by cytolytic T lymphocytes. Immunity 1995; 2: 167-75.
14. Japan Lung Cancer Society, General Rule for Clinical and Pathological Record of Lung Cancer, 5th edn. ; 1999. p. 1-177.
15. Russo V, Traversari C, Verrecchia A, Mottolese M, Natali PG, Bordignon C. Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy. Int J Cancer 1995; 64: 304-8.
16. Brasseur F, Rimoldi D, Lienard D, Lethe B, Carrel S, Arienti F, Suter L, Vanwijck R, Bourlond A, Humblet Y, Vacca A, Conese M, Lahaye T, Degiovanni G, Deraemuecker R, Beauduin M, Sastre X, Salmon E, Dreno B, Jager E, Knuth A, Chevreau C, Suciu S, Lachapelle J-M, Pouillart P, Parmiani G, Lejeune F, Cerottin J-C, Boon T, Marchand M. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer 1995; 63: 375-80.
17. Patard JJ, Brasseur F, Gil Diez S, Radvanyi F, Marcharnd M, Francois P, Abi-Aad A, Van Cangh P, Abbou CC, Copin D, Boon T. Expression of MAGE genes in transitional cell carcinomas of the urinary bladder. Int J Cancer 1995; 64: 60-4.
18. Katano M, Nakamura M, Morisaki T, Fujimoto K. Melanoma antigen-encoding gene-I expression in invasive gastric carcinoma: correlation with stage of disease. J Surg Oncol 1997; 64: 195-20 1.
19. Boon T, Cerottini J-C, Van den Eynde B, van der Bruggen P, Van Pel A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 1994; 12: 337-65.
20. Van den Eynde B, van der Bruggen P. T cell-defined tumor antigens. Curr Opin Immunol 1997; 9: 684-93.
21. Okada M, Kishimoto T. The potential application and limitation of cytokine/growth factor manipulation in cancer therapy. In: Pusztai L, Lewis CE, Yap E (eds) Cell Proliferation in Cancer; Regulatory Mechanisms of Neoplastic Cell Growth. Oxford, UK: Oxford University Press, 1996: 218-44.
22. Tanaka F, Abe M, Akiyoshi T, Nomura T, Sugimachi K, Kishimoto T, Suzuki T, Okada M. The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the interleukin-6 gene using adenovirus vector. Cancer Res 1997; 57: 1335-43.
23. Okada M, Yoshimura N, Kaieda T, Yamamura Y, Kishimoto T. Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules. Proc Natl Acad Sci USA 1981; 78: 7717-21.
24. Whiteside TL, Herberman RB. The role of natural killer cell in immune surveillance of cancer. Curr Opin Immunol 1995; 7: 704-10.
25. Sahin U, Tereci O, Pfreundschuh M. Serological identification of human tumor antigens. Curr Opin Immunol 1997; 9: 709-16.
26. Rogner UC, Wilk K, Steck E, Korn B, Poustka A. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. Genomics 1995; 29: 725-31.
27. Lucas S, De Smet C, Arden KC, Viar CS, Leth B, Lurquin C, Boon T. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 1998; 58: 743-52.
28. Muscatelli F, Walker AP, DePlaen E, Stafford AN, Monaco AP. Isolation and characterization of a new MAGE gene family in the Xp21.3 region. Proc Natl Acad Sci USA 1995; 92: 4987-91.
29. Tureci O, Sahin U, Schobert I, Koslowski M, Schmitt H, Schild H-J, Stenne F, Seitx G, Rammensee H-G, Pfreundschuh M. The SSX-2 gene which I involve in the (X; 18 translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 1996; 56: 4766-72.
30. De Becker O, Arde KC, Boretti M, Vantomme V, DeSmet C, Czekay S, Viar CS, De Plae E, Brasseur F, Chomez P, Van den Eynde B, Boon T, van der Bruggen P. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res 1999; 59: 3157-65.
31. Deslauriers J, Gregoire J. Clinical and surgical staging of non-small cell lung cancer. Chest 2000; 117: 96-103.